Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition

NCT02598167 · clinicaltrials.gov ↗
COMPLETED
Status
223
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Hoffmann-La Roche